b5d38535_t_Equity_Management__Portfolio__Nature
[Company] Genomics [Nature] 
Developing analytics and best-in-class genetic inference technologies to maximise the impact of DNA sequencing on health.
Oxford Spin-out Equity Management: Portfolio
Nature